1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Isis Pharmaceuticals (ISIS) Chairman, CEO and President Stanley T Crooke sells 1,460 Shares

January 17, 2013 | About:

Chairman, CEO and President of Isis Pharmaceuticals (ISIS) Stanley T Crooke sells 1,460 shares of ISIS on 01/16/2013 at an average price of $14 a share.

Isis Pharmaceuticals has a market cap of $1.43 billion; its shares were traded at around $14.24 with and P/S ratio of 12.5.

This is the annual revenues and earnings per share of ISIS over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ISIS.


CEO Recent Trades:



  • Chairman, CEO and President Stanley T Crooke sold 1,460 shares of ISIS stock on 01/16/2013 at the average price of 14. Stanley T Crooke owns at least 877,226 shares after this. The price of the stock has increased by 1.71% since.
  • Chairman, CEO and President Stanley T Crooke sold 89,462 shares of ISIS stock on 09/21/2012 at the average price of 14.63. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has decreased by 2.67% since.
  • Chairman, CEO and President Stanley T Crooke sold 27,074 shares of ISIS stock on 09/13/2012 at the average price of 14.55. Stanley T Crooke owns at least 873,391 shares after this. The price of the stock has decreased by 2.13% since.
  • Chairman, CEO and President Stanley T Crooke sold 75,000 shares of ISIS stock on 09/06/2012 at the average price of 14.62. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has decreased by 2.6% since.

This is the insider trade history vs. stock price of ISIS. For the complete insider trading history of ISIS, click here.




Directors and Officers Recent Trades:



  • SVP, Antisense Research C Frank Bennett sold 309 shares of ISIS stock on 01/16/2013 at the average price of 14. C Frank Bennett owns at least 2,110 shares after this. The price of the stock has increased by 1.71% since.
  • SVP, Development Richard S Geary sold 345 shares of ISIS stock on 01/16/2013 at the average price of 14. Richard S Geary owns at least 4,254 shares after this. The price of the stock has increased by 1.71% since.
  • SVP, Legal and General Counsel Patrick R. O'neil sold 1,296 shares of ISIS stock on 01/04/2013 at the average price of 10.76. Patrick R. O'neil owns at least 1,463 shares after this. The price of the stock has increased by 32.34% since.
  • Sr VP, Development Richard S Geary sold 265 shares of ISIS stock on 01/03/2013 at the average price of 10.84. Richard S Geary owns at least 3,823 shares after this. The price of the stock has increased by 31.37% since.
  • VP, Antisense Drug Discovery Brett P Monia sold 311 shares of ISIS stock on 01/03/2013 at the average price of 10.84. Brett P Monia owns at least 5,288 shares after this. The price of the stock has increased by 31.37% since.


For the complete insider trading history of ISIS, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 5.0/5 (1 vote)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK